Trends in survival outcomes of B-lineage acute lymphoblastic leukemia in elderly patients: Analysis of Surveillance, Epidemiology, and End Results database

Leukemia and Lymphoma

Volumn 56, Issue 8, 2015, Pages 2296-2300

  Murthy, Guru Subramanian Guru ^a   Venkitachalam, Raji ^b,d   Mehta, Paulette ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b The Cochin College   (India)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^d Jr Hospital of Cook County   (United States)

Author keywords

acute lymphoblastic leukemia; Elderly; SEER; survival

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; TREND STUDY; AGE; CANCER REGISTRY; HEALTH SURVEY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84943399527     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.991921     Document Type: Article

References (20)

1. Chiaretti S, Vitale A, Cazzaniga G, et al. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica 2013; 98: 1702-1710.
2. Pulte D, Gondos A, Brenner H. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 2009; 113: 1408-1411.
3. Burmeister T, Schwartz S, Bartram CR, et al.; GMALL study group. Patients age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group. Blood 2008; 112: 918-919.
4. Surveillance, Epidemiology, and End Results Program. SEER∗Stat Database. Incidence-SEER 13 Regs Research Data (with SEER Delay Factors), Nov 2013 Sub (1992-2011) -Linked To County Attributes-Total U.S., 1969-2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014, based on the November 2013 submission. Available from: www.seer.cancer.gov
5. Partridge EE. The National Cancer Data Base: ten years of growth and commitment. CA Cancer J Clin 1998; 48: 131-133.
6. Druker BJ, Sawyers CL, Kantarjian H, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001; 344: 1038-1042.
7. Pulte D, Redaniel MT, Jansen L, et al. Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups. Haematologica 2013; 98: 222-229.
8. Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012; 119: 34-43.
9. Legrand O, Marie JP, Marjanovic Z, et al. Prognostic factors in elderly acute lymphoblastic leukemia. Br J Haematol 1997; 97: 596-602.
10. Robak T, Szmigielska-Kapłon A, Wrzesień-Kus̈ A, et al. Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience. Ann Hematol 2004; 83: 225-231.
11. Moorman AV, Chilton L, Wilkinson J, et al. A population-based cytogenetic study of adults with acute lymphoblastic leukemia. Blood 2010; 115: 206-214.
12. Vignetti M, Fazi P, Cimino G, et al. Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dellAdulto (GIMEMA) LAL0201-B protocol. Blood 2007; 109: 3676-3678.
13. Fielding AK, Rowe JM, Buck G, et al. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Blood 2014; 123: 843-8450.
14. Piccaluga PP, Arpinati M, Candoni A, et al. Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia. Leuk Lymphoma 2011; 52: 325-327.
15. Kantarjian H, Thomas D, Wayne AS, et al. Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia. J Clin Oncol 2012; 30: 3876-3883.
16. Martell MP, Atenafu EG, Minden MD, et al. Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol. Br J Haematol 2013; 163: 458-464.
17. OBrien S, Thomas DA, Ravandi F, et al. Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia. Cancer 2008; 113: 2097-2101.
18. Mohty M, Labopin M, Volin L, et al. Acute Leukemia Working Party of EBMT. Reduced intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood 2010; 116: 4439-4443.
19. Larson RA, Dodge RK, Linker CA, et al. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 1998; 92: 1556-1564.
20. Gökbuget N. How I treat older patients with ALL. Blood 2013; 122: 1366-1375.